Recent studies in glioma cells have shown that acetylation‐regulated metabolic enzymes, such as PGAM4, play key roles in modulating glycolytic flux and chemoresistance, reinforcing the notion that lysine acetylation can act as a fine‐tuning mechanism in metabolic control (Lu et al. 2023). The gene discussed is PGAM4; the disease is glioma.